Caris Life Sciences, Inc.

US$25.23As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CAIHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 17.19%
Biotechnology
Beta (5Y) —
PE TTM 75.71
TSR TTM (16.12%)
Mkt cap US$7.236B
ROIC 47.01%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$26
4.50%
(32.37%)
Hold 3|8|10|6|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.46
0.45
0.46
0.44
8.21%
4.40%
6.51%
6.76%
Revenue$M
469.0
483.1
492.5
510.5
10.65%
9.00%
9.23%
15.29%
Peers (US$7.236B)
Cap (US$)
PE
7.324B
40.17x
Capital
TTM
5Y
10Y
Leveragex
1.918
(0.038)
(0.033)
EBIT/Intx
0.148
0.081
0.081
Own earn%
1.54
150.03
155.50
Sh yield%
30.99
38.43
36.26
Owners
Insiders/Inst%
11.15
55.74
Short interest%
4.65
SBC / revenue%
4.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
24–39
$1 testx
0.0
Incr. ROIC%
18